v3.25.2
Subsequent Events - Additional Information (Details)
6 Months Ended 12 Months Ended
Sep. 05, 2025
USD ($)
Jul. 25, 2025
USD ($)
$ / shares
shares
Jul. 15, 2025
May 31, 2025
USD ($)
Apr. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2025
shares
Jun. 30, 2024
shares
Mar. 31, 2024
shares
Dec. 31, 2022
shares
Subsequent Event [Line Items]                        
Proceeds from short-term debt | $           $ 15,000,000 $ 7,500,000          
Common stock, par value | $ / shares           $ 0.00005 $ 0.00005          
Common stock, shares issued | shares           462,684,023 462,105,898          
Common Stock [Member]                        
Subsequent Event [Line Items]                        
Common stock, par value | $ / shares           $ 0.00005 $ 0.00005 $ 0.00005        
Common stock, shares issued | shares           462,684,023 462,684,023 462,105,898        
Common stock, shares outstanding | shares           462,684,023 462,105,898 321,469,306 462,684,023 321,469,306 321,469,306 318,469,306
Term Loan [Member]                        
Subsequent Event [Line Items]                        
Proceeds from short-term debt | $       $ 7,500,000 $ 7,500,000              
IKENA ONCOLOGY INC                        
Subsequent Event [Line Items]                        
Common stock, par value | $ / shares           $ 0.001 $ 0.001 $ 0.001        
Common stock, shares issued | shares           4,021,458 4,021,458 4,021,458        
Proceeds from issuance of common stock | $               $ 37,421,000        
IKENA ONCOLOGY INC | Common Stock [Member]                        
Subsequent Event [Line Items]                        
Common stock, shares outstanding | shares           4,021,458 4,021,458 4,021,458 4,021,458 4,021,458 4,021,458 3,021,409
Subsequent Event                        
Subsequent Event [Line Items]                        
Prepayment of merger service | $   $ 1,250,000                    
Amount payable on initial term extended services | $   1,250,000                    
Amount of annual FTE rate | $   $ 200,000                    
Subsequent Event | Investor [Member]                        
Subsequent Event [Line Items]                        
Common stock, par value | $ / shares   $ 29.9                    
Common stock, shares subscribed but unissued | shares   2,508,337                    
Proceeds from issuance of common stock | $   $ 75,000,000                    
Subsequent Event | Common Stock [Member]                        
Subsequent Event [Line Items]                        
Stock issued during period, shares, conversion of units | shares   0.003051                    
Common stock, par value | $ / shares   $ 0.001                    
Common stock, shares issued | shares   4,601,375                    
Common stock, shares outstanding | shares   11,181,676                    
Subsequent Event | Term Loan [Member]                        
Subsequent Event [Line Items]                        
Proceeds from short-term debt | $ $ 22,500,000     $ 7,500,000 $ 7,500,000              
Subsequent Event | Promissory Note [Member]                        
Subsequent Event [Line Items]                        
Debt instrument, face amount | $   $ 8,900,000                    
Debt instrument, interest rate, stated percentage   4.61%                    
Percentage of prepay outstanding balance for promissory note   50.00%                    
Subsequent Event | IKENA ONCOLOGY INC                        
Subsequent Event [Line Items]                        
Reverse stock split   1-for-12 reverse stock split one new share of Company common stock for every 12 shares of outstanding Company common stock                  
Reverse stock split ratio     0.0833